Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding:: A multicenter trial

被引:129
作者
de la Peña, J
Brullet, E
Sanchez-Hernández, E
Rivero, M
Vergara, M
Martin-Lorente, JL
Suárez, CG
机构
[1] Hosp Univ Marques de Valdecilla, Serv Aparato Digest, Santander 39008, Spain
[2] Hosp Sabadell CS Parc Tauli, Sabadell, Spain
[3] Complejo Hosp Cristal Pinor, Orense, Spain
[4] Hosp Gen Yague, Burgos, Spain
关键词
D O I
10.1002/hep.20584
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
beta-Blockers and endoscopic variceal ligation (EVIL) have proven to be valuable methods in the prevention of variceal rebleeding. The aim of this study was to compare the efficacy of EVL combined with nadolol versus EVL alone as secondary prophylaxis for variceal bleeding. Patients admitted for acute variceal bleeding were treated during emergency endoscopy with EVL or sclerotherapy and received somatostatin for 5 days. At that point, patients were randomized to receive EVL plus nadolol or EVL alone. EVL sessions were repeated every 10 to 12 days until the varices were eradicated. Eighty patients with cirrhosis (alcoholic origin in 66%) were included (Child-Turcotte-Pugh A, 15%; B, 56%; C, 29%). The median follow-up period was 16 months (range, 1-24 months). The variceal bleeding recurrence rate was 14% in the EVL plus nadolol group and 38% in the EVL group (P =.006). Mortality was similar in both groups: five patients (11.6%) died in the combined therapy group and four patients (10.8%) died in the EVL group. There were no significant differences in the number of EVL sessions to eradicate varices: 3.2 +/- 1.3 in the combined therapy group versus 3.5 +/- 1.3 in the EVIL, alone group. The actuarial probability of variceal recurrence at I year was lower in the EVL plus nadolol group (54%) than in the EVL group (77%; P =.06). Adverse effects resulting from nadolol were observed in 11% of the patients. In conclusion, nadolol plus EVL reduces the incidence of variceal rebleeding compared with EVL alone. A combined treatment could lower the probability of variceal recurrence after eradication.
引用
收藏
页码:572 / 578
页数:7
相关论文
共 38 条
[1]   PROPRANOLOL IN THE PREVENTION OF RECURRENT UPPER GASTROINTESTINAL-BLEEDING IN PATIENTS WITH CIRRHOSIS UNDERGOING ENDOSCOPIC SCLEROTHERAPY - A RANDOMIZED CONTROLLED TRIAL [J].
AVGERINOS, A ;
REKOUMIS, G ;
KLONIS, C ;
PAPADIMITRIOU, N ;
GOUMA, P ;
POURNARAS, S ;
RAPTIS, S .
JOURNAL OF HEPATOLOGY, 1993, 19 (02) :301-311
[2]   Endoscopic sclerotherapy versus variceal ligation in the long-term management of patients with cirrhosis after variceal bleeding - A prospective randomized study [J].
Avgerinos, A ;
Armonis, A ;
Manolakopoulos, S ;
Poulianos, G ;
Rekoumis, G ;
Sgourou, A ;
Gouma, P ;
Raptis, S .
JOURNAL OF HEPATOLOGY, 1997, 26 (05) :1034-1041
[3]  
Baroncini D, 1997, ENDOSCOPY, V29, P235
[4]   Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: A meta-analysis [J].
Bernard, B ;
Lebrec, D ;
Mathurin, P ;
Opolon, P ;
Poynard, T .
JOURNAL OF HEPATOLOGY, 1997, 26 (02) :312-324
[5]   EFFECTS OF PROPRANOLOL ON AZYGOUS VENOUS-BLOOD FLOW AND HEPATIC AND SYSTEMIC HEMODYNAMICS IN CIRRHOSIS [J].
BOSCH, J ;
MASTI, R ;
KRAVETZ, D ;
BRUIX, J ;
GAYA, J ;
RIGAU, J ;
RODES, J .
HEPATOLOGY, 1984, 4 (06) :1200-1205
[6]  
BURROUGHS AK, 1999, NEW ENGL J MED, V340, P33105
[7]   Pharmacological treatment of portal hypertension: An evidence-based approach [J].
D'Amico, G ;
Pagliaro, L ;
Bosch, J .
SEMINARS IN LIVER DISEASE, 1999, 19 (04) :475-505
[8]  
DAMICO G, 1995, HEPATOLOGY, V22, P332, DOI 10.1002/hep.1840220145
[9]   Variceal ligation compared with endoscopic sclerotherapy for variceal hemorrhage:: Prospective randomized trial [J].
de la Peña, J ;
Rivero, M ;
Sanchez, E ;
Fábrega, E ;
Crespo, J ;
Pons-Romero, F .
GASTROINTESTINAL ENDOSCOPY, 1999, 49 (04) :417-423
[10]   Variceal ligation plus nadolol compared with variceal ligation after bleeding. Multicenter randomized trial. Preliminary analysis [J].
De La Pena, J ;
Rivero, M ;
Suarez, CG ;
Brullet, E ;
Campo, R ;
Vergara, M ;
Hernandez, ES ;
Lorente, JLM .
GASTROENTEROLOGY, 2003, 124 (04) :A733-A733